Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling
Abstract INTRODUCTION While the anti‐amyloid‐lowering immunotherapies provide the first disease‐targeting therapies for the treatment of Alzheimer's disease, there remain harmful adverse events causing hesitation among patients, families, physicians, and regulatory bodies. Though these drugs have be...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2026-01-01
|
| coleção: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/trc2.70201 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|